Turn Therapeutics (TTRX) announces that its common stock is scheduled to commence trading, October 8, 2025, on the Nasdaq Capital Market under ticker symbol “TTRX.” The Company’s registration statement on Form S-1 was declared effective by the U.S. Securities and Exchange Commission September 30, 2025. Clear Street served as financial advisor to the company. Davis, Polk, and Wardwell acted as legal counsel.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential